Showing results (101-110 of 117) with videos related to
Sort By:
Pageof 12
Learning & Memory (Cold Spring Harbor, N.Y.)|January 17, 2013
Role of medial prefrontal cortex Narp in the extinction of morphine conditioned place preferenceAshley M Blouin, Sungho Han, Anne M Pearce, et al.Science Advances|April 20, 2019
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogeneticsMikail Weston, Teresa Kaserer, Angela Wu, et al.Epilepsia|September 12, 2021
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome miceNicole A Hawkins, Manuel Jurado, Tyler T Thaxton, et al.Neurobiology of Disease|May 22, 2003
Molecular investigation of TBP allele length: a SCA17 cellular model and population studySuzanne J Reid, Mark I Rees, Willeke M C van Roon-Mom, et al.Proceedings of the National Academy of Sciences of the United States of America|October 5, 2017
Long-term restoration of visual function in end-stage retinal degeneration using subretinal human melanopsin gene therapySamantha R De Silva, Alun R Barnard, Steven Hughes, et al.International Journal of Molecular Sciences|November 13, 2020
Platelet-Reactive Antibodies in Patients after Ischaemic Stroke-An Epiphenomenon or a Natural Protective MechanismYoung Eun Park, Rushi Penumarthy, Paul P Sun, et al.Scientific Reports|October 14, 2020
Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in miceToshiya Nishi, Shinichi Kondo, Maki Miyamoto, et al.Cellular Signalling|May 19, 2015
Inhibition of glutamate regulated calcium entry into leukemic megakaryoblasts reduces cell proliferation and supports differentiationTania Kamal, Taryn N Green, Marie-Christine Morel-Kopp, et al.Lancet (London, England)|January 21, 2014
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trialRobert E MacLaren, Markus Groppe, Alun R Barnard, et al.Science Translational Medicine|December 21, 2012
Long-term follow-up after gene therapy for canavan diseasePaola Leone, David Shera, Scott W J McPhee, et al.Pageof 12